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Purpose. Older cancer survivors required medical care during the COVID-19 pandemic despite 
infection risks, but there are limited data on medical care in this age group.  
Methods. We evaluated care disruptions in a longitudinal cohort of non-metastatic breast cancer 
survivors ages 60-98 from five US regions (n=321). Survivors completed a web-based or 
telephone survey from May 27, 2020 to September 11, 2020. Care disruptions included self-
reported interruptions in ability to see doctors, receive treatment or supportive therapies, or fill 
prescriptions. Logistic regression models evaluated bivariate and multivariate associations 
between care disruptions and education, medical, psychosocial and COVID-19-related factors. 
Multivariate models included age, county COVID-19 rates, comorbidity and post-diagnosis time.   
Results. There was a high response rate (n=262, 81.6%). Survivors were 32.2 months post-
diagnosis (SD 17.5, range 4-73). Nearly half (48%) reported a medical disruption. The 
unadjusted odds of care disruptions were significantly higher with more education (OR 1.23 per 
one-year increase, 95% CI 1.09-1.39, p =0.001) and greater depression (OR 1.04 per one-point 
increase in CES-D score, CI 1.003-1.08, p=0.033); tangible support decreased the odds of 
disruptions (OR 0.99, 95% CI 0.97-0.99 per one-point increase, p=0.012). There was a trend for 
associations between disruptions and comorbidity (unadjusted OR 1.13 per 1 added comorbidity, 
95% CI 0.99-1.29, p=0.07). Adjusting for covariates, only higher education (p=0.001) and 
tangible social support (p=0.006) remained significantly associated with having care disruptions.  
Conclusions. Older breast cancer survivors reported high rates of medical care disruptions during 








The COVID-19 pandemic has had broad effects on medical care delivery, with delays in 
routine care and postponement of non-COVID-19 related services [1][2]. The risks of delaying 
routine care during the COVID-19 pandemic have been high among those with chronic illnesses, 
including cancer [3]. These same groups also have the highest risk of severe complications and 
mortality from COVID-19 infection. Cancer care guidelines during the pandemic have focused 
on treatment for new patients [4][5]. There has been less attention to the impact of the pandemic 
on existing cancer survivors or associated disruptions in care. A proportion of long-term cancer 
survivors are in older age groups and may be especially vulnerable to disruptions that could 
adversely affect survivorship care [6].  Additionally, pandemic-related social isolation could 
exacerbate depression, anxiety and sleep disturbances after cancer, increasing the need for 
medical care [7][8].  
In this study, we describe the impact of the COVID-19 pandemic on the medical care of 
older breast cancer survivors enrolled in the Thinking and Living with Cancer (TLC) 
longitudinal cohort study. We describe the prevalence of care disruptions and explore factors that 
might be associated with disruptions that occurred during the first six-months of the pandemic. 
The results are intended to inform survivorship care during and beyond the pandemic.   
 
Methods 
TLC is an Institutional Review Board approved study that has been reported previously 
[9] and was conducted across sites in five regions . The COVID survey used in this study was 







The target population included 705 survivors recruited between August 1, 2010 and 
March 1, 2020 that were 60 years or older and newly diagnosed with AJCC stage 0-III breast 
cancer at study entry. Those with neurological disorders or hearing or vision impairments that 
precluded assessment, had a history of other cancers or any prior chemotherapy, or were non-
English-speaking were excluded.  
For the current study, we excluded survivors were no longer active in the study, including 
those that had had a recurrence, had completed all study follow-up, dropped out of the study, or 
died (n=367). We also excluded survivors with missing treatment data or who had been 
diagnosed with COVID-19 (n=17).  Among the 321 women eligible for this study, 81.6% 
(n=262) completed the COVID-19 survey and constitute the analytic sample (Figure 1). The 
survivors completing the survey were similar to the non-completers, except they were more 
likely to be White (84.7% vs. 72.9%, respectively, p=.03). The analytic sample was also similar 
to the overall target population, except for having slightly more comorbidities (3.0 [SD 2.1] vs 
2.5 [SD 1.9], p<.01) and a lower rate of chemotherapy receipt (20.6% vs 29.7%, p<.01). 
Data Collection 
As a part of TLC assessments survivors has completed a baseline, pre-systemic therapy 
survey at enrollment with annual follow-up. The COVID survey was developed and reviewed by 
a committee of TLC investigators and included standard study assessments, items from the 
National Institute of Mental Health (NIMH) Psychosocial Impact of COVID-19 survey [10], and 
additional COVID-related measures. The survey was conducted online between May 27, 2020- 
September 11, 2020.  Participants who did not have an email address on file were called to 





automatically re-sent every week for 3 weeks; if no response, study staff called the participant to 
complete the survey by phone. Most completed the survey online (87.2%).   
Measures 
The outcome measure was having any medical care disruption during the pandemic 
(yes/no) based on response to items adapted from the NIMH-NIH survey [10]: ability to see 
doctors, receive medical treatment, fill prescriptions, or receive supportive therapies (e.g. 
physical therapy, massage, acupuncture).  
We examined potential factors hypothesized to be associated with care disruptions. 
Pandemic-specific factors included cumulative per capita rates of COVID-19 deaths in the 
county of the participants’ residence through the week of survey completion [11][12]. Pandemic-
related worry was assessed  based on items from the NIMH-NIH survey [10]: job loss (self or 
family), loss of insurance, and worries about being infected with COVID-19, food access, 
financial issues, housing, and transportation during the pandemic; each item was rated on a 1-10 
scale from not worried to very worried.  
Socio-demographic factors include age, race (White vs, non-White) and years of 
education. Clinical factors included AJCC cancer stage, time from diagnosis and type of 
systemic therapy at enrollment and number of comorbidities on the last pre-COVID assessment. 
Psychosocial variables from the last pre-COVID assessment included: anxiety (20-item State 
Trait Anxiety Inventory [STAI])[13], depression (20-item Center for Epidemiologic Studies–
Depression [CES-D] Scale, [14] two questions from the CES-D about sleep disturbance,  
emotional and tangible support subscales of the MOS [15], and quality of life (Functional 






Statistical Analysis  
Univariate logistic regression methods were used as a first step to describe the association 
between having medical care disruption vs. not and covariates. Variables with p<0.1 association 
in the univariate logistic regression were then considered in a multivariable logistic regression 
model. Age, education, time from diagnosis, cumulative per capita rate of deaths, and 
comorbidities were also retained in the final model for face validity. We determined the final 
multivariable model using backward selection with a threshold of p<0.1. Goodness-of-fit was 
reported based on Akaike Information criterion (AIC), Bayesian Information Criterion (BIC), 
and the concordance statistics (C-statistics). Odds ratios and corresponding 95% confidence 
intervals were provided for all analyses. Statistical significance was determined with a two-sided 
p-value <0.05. All analyses were conducted in SAS Version 9.4.b (SAS Institute Inc., Cary, NC, 
USA). 
Results 
The survivors’ average age was 68 years (range 60-82) and 97.7% had internet access.  
The majority (66.4%) were >2 years from breast cancer diagnosis with 22.8% diagnosed within 
the preceding year (Table 1). Nearly one-half (48%) of survivors reported having had any 
medical disruption during the first six months of the pandemic. Disruptions included 
interruptions in seeing or speaking to their doctor (reported by 48.4%), disruptions in medical 
treatments (51.2%), and difficulty obtaining supportive care therapies (40.2%). While the mean 
number of medications was 3.8 (SD 2.2), only 4.7% of survivors reported difficulty filling 
prescriptions.  
Several factors were associated with having medical care disruptions in bivariate analyses 





disruptions (OR 1.13, 95% CI 0.99-1.29, p=0.071). More years of education was significantly 
associated with the odds of reporting medical care disruptions (OR 1.23 per one year increase, 
95% CI 1.09-1.39, p =0.001). More tangible support pre-COVID was associated with not having 
medical disruptions during the pandemic (p=0.012). Survivors with higher CES-D scores (more 
depressive symptoms) at their last pre-COVID assessment were also more likely to report 
medical disruptions (OR 1.04 per one-point increase in depressive symptoms, 95% CI 1.003-
1.080, p=0.033). Participants with better quality of life pre-COVID were less likely to experience 
medical disruptions (OR 0.95 per one point increase in FACT-G score, 95% CI 0.932-0.980, 
p<0.001). There were no significant associations of care disruptions with cancer-specific factors 
such as time since diagnosis, stage or initial therapy.  
In multivariable-adjusted analyses, only tangible social support and education remained 
significantly associated with medical disruptions: the odds of reporting disruptions were lower 
for those with more tangible social support pre-COVID (OR 0.98 per 1-point per increase, 95% 
CI 0.97-0.995, p=0.006) and 23% higher for each increase in years of education (OR 1.23, 95% 
CI 1.09-1.39, p=0.001) (Table 1).   
Discussion 
This study examined health care access among older US breast cancer survivors in the 
first six-months of the COVID-19 pandemic. Nearly one-half of these older survivors reported 
experiencing medical care disruptions. Having more tangible social support reduced the odds of 
having medical care disruptions during the pandemic. Survivors with more education reported 
more disruptions than those with less education though the mean number of years of education 





About half the survivors reported difficulties seeing or speaking with their doctors or 
receiving supportive therapies (including integrative treatments and physical therapy). The latter 
finding may reflect some institutions’ protocols prioritizing medical therapies rather than 
supportive care during the pandemic [1][3][17]. Since these older cancer survivors are part of a 
longitudinal cohort study, we may be able to assess the impact of care disruptions on subsequent 
quality of life in the future.  
The rate of medical care disruptions among older breast cancer survivors that we 
observed was consistent with rates reported from general populations. The Centers for Disease 
Control (CDC) reported that approximately 41% of U.S. adults delayed or avoided routine and 
urgent medical care due to the COVID-19 pandemic [18] and studies worldwide similarly 
indicated a rise in missed medical appointments during the pandemic [19][20]. Most studies that 
included cancer patients or survivors have focused on newly diagnosed and younger patients[5], 
with limited information on disruptions experienced by long-term or older cancer survivors [18-
2][21]. Our cohort was on average, two to three years from diagnosis and might be less 
vulnerable to care disruptions as women newly diagnosed with breast cancer. However, older 
survivors have more comorbidities than younger patients so care disruptions could have a larger 
impact on health.  
The results of this study also highlight how common issues affecting cancer survivors 
such as social support can buffer disruptions in medical care during the pandemic. This 
observation may reflect the direct impact of social support on transportation to medical care or 
arranging appointments. Alternatively, social support may be capturing other aspects of cancer 
survivors’ lives not captured by our measures, including having more social connections. The 





Nurses’ Health Study demonstrated that the degree of social support in breast cancer survivors 
affected physical function and adverse cancer-related symptoms [22], and other studies have 
shown associations between social isolation and increased mortality for cancer survivors [23]. 
However, there is less literature on the impact of social support specifically on obtaining medical 
care.  
Contrary to expectation we found that as years of education increased the odds of 
reporting medical care disruptions increased. This may be related to higher education being 
associated with more general awareness of the need for health maintenance, as lower education 
and health literacy has been linked to less use of screening and routine preventive care 
appointments [24]. Alternatively, higher education may be a proxy for a greater desire for 
medical care or increased caution about COVID risk. It will be important to compare our 
findings to newer reports on health care disruptions.   
The study has many strengths including the ability to consider COVID-related medical 
care disruptions in the context of an ongoing longitudinal cohort of breast cancer survivorship, 
focusing on older cancer survivors, and having data on preexisting factors that could affect 
survivors’ ability to respond to unexpected events. However, there are limitations that should be 
considered in evaluating our results. First, fewer non-White survivors in the cohort responded to 
the survey than White participants. Non-White adults have had higher infection rates and greater 
economic losses than White adults during the pandemic [25]. To the extent that older non-White 
survivors were under-represented, we could have under-estimated the overall rate of medical 
care disruptions among breast cancer survivors. Second, our cohort was highly educated and the 
majority had health insurance through Medicare, so their experiences may not reflect access to 





of COVID-19 deaths, there are variations in effects of state or local lockdown orders, social 
distancing, and media messages that we did not capture in our measures.   
Overall, this study shows that during the first six months of the COVID-19 pandemic 
nearly 50% of older breast cancer survivors experienced some type of disruption in medical care. 
It will be important to determine if these disruptions persist or resolve as a larger proportion of 
the population becomes vaccinated or whether the initial disruptions in care will have long-
lasting effects on health and function. Until then, older breast cancer survivors appear vulnerable 
to losses in medical care and should be considered in future studies of the growing impact of the 
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A sample for evaluation of medical disruptions in older breast cancer survivors. Participants 
were excluded if they were not active (i.e. had completed the study, dropped out, or deceased) 
since the start of survey data collection. The percentage who completed and refused was 
calculated among those active and eligible to complete the survey. Eligibility for completing the 
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COVID diagnosis only (n=3)
No treatment only (n=13)







Table 1: Odds of Having Medical Care Disruptions During the COVID19 Pandemic 






Factors Associated with Having Medical Care 
Disruptions  








Age, years 68.0 (5.2) 67.8 (5.5) 0.993 (0.95,1.04) 0.753 0.99 (0.95,1.04) 0.548 
Race      -----  
     Non-White 47.5 (19) 52.5 (21) 1.21 (0.62,2.37) 0.580   
     White 52.3 (116) 47.7 (106) Reference     
Education, years 15.1 (2.3) 16.0 (2.0) 1.22 (1.08,1.37) <.001 1.23 (1.09,1.39) 0.001 
Clinical factors       
Months from diagnosis 33.5 (18.0) 30.6 (16.7) 0.99 (0.98,1.01) 0.191 0.99 (0.97,1.01) 0.168 
Stage (AJCC v.6)       
     0-I   52.2 (108) 47.8 (99) referent  -----  
     II or III  48.9 (22) 51.1 (23) 1.14 (0.60,2.17) 0.689   
Systemic Treatment      -----  
Chemotherapy +/-
hormonal  
45.1 (23) 54.9 (28) 1.38 (0.75,2.55) 0.307   
Hormonal only 53.1 (112) 46.9 (99) referent    
Comorbidities prior to 
COVID, number 
2.7 (1.8) 3.1 (2.0) 1.13 (0.99,1.29) 0.071 1.09 (0.94,1.26) 0.238 
Prescription drugs prior 
to COVID, number 
3.6 (2.2) 4.0 (2.6) 1.08 (0.97,1.19) 0.170 ------  
COVID-related factors  
Family/household 
member lost their job  
34.5 (10) 65.5 (19) 2.20 (0.98,4.93) 0.056 ------  
COVID-related worries, 
per 1-point increase2 
16.8(6.5) 18.5(9.2) 1.03 (1.00,1.06) 0.085 ------  
Per capita COVID deaths 
in county per 10003 
0.9 (0.9) 0.8 (0.8) 0.86 (0.65,1.15) 0.319 0.80 (0.58,1.11) 0.179 
Psychosocial factors prior to COVID 
Depressive symptoms 4 5.5 (5.4) 7.5 (8.6) 1.04 (1.00,1.08) 0.033 ------  
Anxiety5  27.5 (5.5) 28.8 (7.5) 1.03 (0.99,1.07) 0.120 ------  
Tangible social support, 
per one point increase6  
83.8 (19.3) 76.9 (23.8) 0.99 (0.97,1.00) 0.012 0.98 (0.97,1.00) 0.006 
Emotional support  
per one point increase7 
82.7 (17.9) 78.1 (20.4) 0.987 (0.98,1.00) 0.053 ------  
Sleep disturbance7 52.4% (44) 47.6 (40) 0.95 (0.57,1.60) 0.849 ------  
FACT– G Total, per 1 
point increase 8 
71.0 (9.1) 66.2 (11.8) 0.96 (0.93,0.98) <.001 ------  
Model fit statistics                                                                                              BIC=365.11; AIC=340.37; C=0.673 







2 COVID-related worries based on 7-items from COVID survey. Scores range from 7-70, with higher 
scores reflecting more covid worries. 
 
3 Based on cumulative death rates per capita in county of residence from pandemic to date of interview 
per 1000 based on data reported to the NY Times [11] and the US Census [12].  
 
4 Based on the CES-D, Center for Epidemiologic Studies Depression Scale [Error! Bookmark not 
defined.]. Scores range from 0-60, with higher scores reflecting more psychological distress. 
 
5 Based on the State-Trait Anxiety Inventory [13]. Scores range from 20 to 80, with higher scores 
reflecting more anxiety. 
 
6 Based on the normalized MOS-Tangible social support [15]. Scores range from 0 to 100, with higher 
scores reflecting more tangible social support. 
 
7 The presence of a sleep disturbance (yes/no) was determined from the endorsement of one or both of 2 
questions [25]from CES-D: During the last 7 days, I have been sleeping well” (with subjects who 
reported “not at all” or “a little bit” coded as having a sleep disturbance) and “During the past week, my 
sleep was restless” (with subjects who reported “occasionally or moderate amount of time” or “most or all 
the time” coded as having a sleep disturbance.  
 
8 Based on the FACT-G [16]. Scores range from 0 to 84, with higher scores reflecting better functioning. 
 
 
 
 
 
 
 
 
 
 
 
 
  
